Treatment Outcome of Haematopoietic Stem Cell Transplant in Fanconi Anaemia: Experience from a Low- and Middle-Income Country | [Journal of College of Physicians and Surgeons--Pakistan : JCPSP • 2025]

Author(s):

1. Hashim Khan: Department of Clinical Haematology, Armed Forces Bone Marrow Transplant Centre (AFBMTC), Combined Military Hospital,Rawalpindi,Pakistan

2. Tariq Ghafoor: Department of Haemotology and Oncology, Armed Forces Bone Marrow Transplant Centre (AFBMTC), Combined Military Hospital, Rawalpindi, Pakistan

3. Tariq Azam Khattak: Department of Clinical Haematology, Armed Forces Bone Marrow Transplant Centre (AFBMTC), Combined Military Hospital,Rawalpindi,Pakistan

4. Nighat Shahbaz: Department of Clinical Haematology, Armed Forces Bone Marrow Transplant Centre (AFBMTC), Combined Military Hospital,Rawalpindi,Pakistan

5. Munazza Nabi Awan: Department of Clinical Haematology, Armed Forces Bone Marrow Transplant Centre (AFBMTC), Combined Military Hospital,Rawalpindi,Pakistan

6. Awais Siddiq: Department of Clinical Haematology, Armed Forces Bone Marrow Transplant Centre (AFBMTC), Combined Military Hospital,Rawalpindi,Pakistan

Abstract:

Objective: To determine the outcome of haematopoietic stem cell transplantation (HSCT) in Fanconi anaemia (FA) patients. Study Design: Retrospective observational study. Place and Duration of the Study: Department of Clinical Haematology, Armed Forces Bone Marrow Transplant Centre, CMH Rawalpindi, Pakistan, from February 2009 to December 2023. Methodology: The data of 41 cases of FA undergoing HSCT were analysed retrospectively, from February 2009 to December 2023. Cases transformed into myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML) were excluded. All cases of FA under 18years of age having fully HLA-matched HSCT were included. A non-myeloablative conditioning regimen consisting of Flu120/Cy30/ATG20 was used. Descriptive statistics were obtained for harvest source, complications, graft success, and survival. Results: The study included 27 (65.9%) boys and 14 (34.1%) girls with a mean age of 10.3 ± 3.1 years. Bone marrow as a stem cell source was harvested in 33 (80.5%) cases. Cyclosporin-induced hypertension was documented in 36 (87.8%) cases. The cumulative incidence of acute GVHD and chronic GVHD was 34.1% and 32.3%, respectively. Six (14.6%) patients had graft failure, three had primary graft failure, and three had secondary graft failure. At a median follow-up of 63.8 ± 46.1 months, the overall survival (OS) rate was 73.2% and the disease-free survival (DFS) rate was 73.2%. Conclusion: Overall survival of more than 70% is promising but inferior to that in developed countries. Graft failure, infectious complications, and GVHD remain major challenges requiring improvement in the developing countries.

Page(s): 242-246

DOI: 10.29271/jcpsp.2025.02.242

Published: Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 35, Issue: 2, Year: 2025

Keywords:

Pakistan , Fanconi anaemia , Haematopoietic stem cell transplantation

References:

[1] Tuysuz G,Guler E,Ozel D,Kupesiz A .2019 .Results of allogenic hematopoietic stem cell Transplantation in fanconi anemia caused by bone marrow failure: Single-regimen, single-center experience of 14 years. Biol Blood Marrow Transplant, 05(10) : 2017-23.

[2] Rosenberg PS,Tamary H,Alter BP .2011 .155A(8. Am J Med Genet A, 34087 : 1877-83.

[3] Siddiqui F,Ansari S,Agha A,Nusrat N,Munzir S,Shan S .2020 .Chromosomal breakage in fanconi anemia and consanguineous marriages: A social dilemma for developing countries. Cureus, 10(9) : .

[4] Repczynska A,Pastorczak A,Pokora KB,Sadowska JS,Drozniewska M,Mlynarski W .2020 .Novel FANCA mutation in the rst fully-diagnosed patient with fanconi anemia in Polish population - Case report. Mol Cytogenet, 10 : 33.

[5] Lu Y,Xiong M,Sun RJ,Zhao YL,Zhang JP,Cao XY .2021 .Hematopoietic stem cell transplantation for inherited bone marrow failure syndromes: Alternative donor and disease-speci c conditioning regimen with unmanipulated grafts. Hematology, 1876393(1) : 134-43.

[6] Dufour C .2022 .Modern management of Fanconi anemia. Hematology Am Soc Hematol Educ Program2022;, 10 : 649-57.

[7] Hutt D,Kenyon M .2018 .The Europeanblood and marrow trans-plantation textbook for nurses. Under the auspices of EBMT [Internet]. Cham, : .

[8] Iftikhar R,Chaudhry QUN,Satti TM,Mahmood SK,Ghafoor T,Shamshad GU .2020 .Comparison of conventional cyclophosphamide versus udarabine-based conditioning in high-risk aplastic anemia patients undergoing matched-related donor transplantation. Clin Hematol Int, 200426(2) : 82-91.

[9] Dignan FL,Clark A,Amrolia P,Cornish J,Jackson G,Mahendra P .2012 .Haemato-oncology task force of British committee for standards in haematology. British society for blood and marrow transplantation. Diagnosis and management of acute graft-versus-host disease. Br J Haematol, 09129(1) : 2141-45.

[10] Vigorito AC,Campregher PV,Storer BE,Carpenter PA,Moravec CK,Kiem HP .2009 .Evaluation of NIH consensus criteria for classi cation of late acute and chronic GVBHloDo. -03-208983., 10(3) : 702-8.

[11] Yadav SP,Raj R,Uppuluri R,Choudhary D,Doval D,Dua V .2023 .Outcome of allogeneic stem cell transplant for fanconi anemia in India. Pediatr Hematol Oncol, 2286971(2) : 169-71.

[12] Gluckman E,Auerbach AD,Horowitz MM,Sobocinski KA,Ash RC,Bortin MM .1995 .Bone marrow transplantation for Fanconi anemia. Blood, 86(7) : 2856-62.

[13] Stepensky P,Shapira MY,Balashov D,Trakhtman P,Skorobogatova E,Rheingold L .2011 .Bone marrow transplantation for fanconi anemia using udarabine-based conditioning. Biol Blood Marrow Transplant, 01(9) : 1282-8.

[14] Bon C,Ribeiro L,Nichele S,Loth G,Kuwahara CMD,Koliski AMD .2014 .Excellent outcome for fanconi anemia patients undergoing hematopoietic stem cell transplantation (HSCT) without radiation: A single center experience on 103 patients. Biol Blood Marrow, 11(2) : 1083-8791.

[15] Fink O,Even-Or E,Avni B,Grisariu S,Zaidman I,Schejter YD .2023 .Two decades of stem cell transplantation in patients with fanconi anemia: Analysis of factors a ecting transplant outcomes. Clin Transplant, 10(1) : .

[16] Doval D,Choudhary D,Sharma SK,Khandelwal V,Kumar M,Handoo A .2020 .Hematopoietic stem cell transplantation for fanconi anemia: A single center experience from India. Indian J Hematol Blood Transfus, 10(3) : 565-8.

[17] Wang L,Romero M,Ratajczak P,Leboeuf C,Belhadj S,de Latour RP .2013 .Increased apoptosis is linked to severe acute GVHD in patients with fanconi anemia. Bone Marrow Transplant, 10(6) : 237-53.

[18] Guardiola P,Socie G,Li X,Ribaud P,Devergie A,Esperou H .2004 .Acute graft-versus-host disease in patients with fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: Risk factors and in uence on outcome. -06-2146., 10(1) : 73-7.

[19] Kumar R,Kimura F,Ahn KW,Hu ZH,Kuwatsuka Y,Klein JP .2016 .Comparing outcomes with bone marrow or peripheral blood stem cells as graft source for matched sibling transplants in severe aplastic anemia across di erent economic regions. Biol Blood Marrow Transplant, 01(5) : 932-40.

[20] de Latour RP,Porcher R,Dalle JH,Aljurf M,Korthof ET,Svahn J .2013 .Allogeneic hematopoietic stem cell transplantation in fanconi anemia: The European group for blood and marrow transplantation experience. -01-479733., 10(26) : 4279-86.

Citations

Downloads

Views